OPTIMIZING TREATMENT WITH LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Loebel, Antony [1 ,2 ]
Silva, Robert [1 ,2 ]
Goldman, Robert [1 ,2 ]
Watabbe, Kei [1 ,2 ]
Pikalov, Andrei [1 ,2 ]
Cucchiaro, Josephine [1 ,2 ]
Kane, John M. [3 ]
机构：
[1] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Marlborough, MA USA
[2] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
[3] Hofstra North Shore LIJ Sch Med, Psychiat & Mol Med, Uniondale, NY USA
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
2114720
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [21] Pregabalin for the treatment of fibromyalgia syndrome - Results of a randomized, double-blind, placebo-controlled trial
    Crofford, LJ
    Rowbotham, MC
    Mease, PJ
    Russell, IJ
    Dworkin, RH
    Corbin, AE
    Young, JP
    LaMoreaux, LK
    Martin, SA
    Sharma, U
    ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1264 - 1273
  • [22] Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial
    Higuchi, Teruhiko
    Iyo, Masaomi
    Kwon, Jun Soo
    Chou, Yuan-Hwa
    Chen, Hsing-Kang
    Chen, Jen-Yeu
    Chen, Tzu-Ting
    Huang, San-Yuan
    Lee, Jung-Sik
    Saeki, Yuichi
    Tanaka, Hisashi
    Wang, Tzong-Shi
    Wu, Bo-Jian
    Katoh, Takao
    Ishigouoka, Jun
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (03)
  • [23] Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Phillips, Debra
    Xu, Jane
    Kalali, Amir H.
    Schweizer, Edward
    Pikalov, Andrei
    Loebel, Antony
    AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (09): : 957 - 967
  • [24] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Shiina, Akihiro
    Shirayama, Yukihiko
    Niitsu, Tomihisa
    Hashimoto, Tasuku
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Haraguchi, Tadashi
    Kanahara, Nobuhisa
    Shiraishi, Tetsuya
    Fujisaki, Mihisa
    Fukami, Goro
    Nakazato, Michiko
    Iyo, Masaomi
    Hashimoto, Kenji
    ANNALS OF GENERAL PSYCHIATRY, 2010, 9
  • [25] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Akihiro Shiina
    Yukihiko Shirayama
    Tomihisa Niitsu
    Tasuku Hashimoto
    Taisuke Yoshida
    Tadashi Hasegawa
    Tadashi Haraguchi
    Nobuhisa Kanahara
    Tetsuya Shiraishi
    Mihisa Fujisaki
    Goro Fukami
    Michiko Nakazato
    Masaomi Iyo
    Kenji Hashimoto
    Annals of General Psychiatry, 9
  • [26] Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial
    Akhondzadeh, S
    Nejatisafa, AA
    Amini, H
    Mohammadi, MR
    Larijani, B
    Kashani, L
    Raisi, F
    Kamalipour, A
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (06): : 1007 - 1012
  • [27] A randomized, double-blind, placebo-controlled trial of aripiprazole in the treatment of adolescents with schizophrenia: A report on tolerability
    Carson, William H.
    Robb, Adelaide S.
    Van-Beek, Alet
    Johnson, Brian
    Mallikaarjun, Suresh
    Ivanova, Svetlana
    Forbes, Robert A.
    Marcus, Ronald N.
    Nyilas, Margaretta
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 880 - 881
  • [28] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Iniesta, Raquel
    Cobo, Jesus
    Araya, Susana
    Roca, Mercedes
    Serrano-Blanco, Antoni
    Teba, Fernando
    Ochoa, Susana
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1552 - 1557
  • [29] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
    Akhondzadeh, Shahin
    Tabatabaee, Maryam
    Amini, Homayoun
    Abhari, Seyed Ali Ahmadi
    Abbasi, Seyed Hesamedin
    Behnam, Behnaz
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 179 - 185
  • [30] VARENICLINE TREATMENT FOR SMOKING CESSATION IN PEOPLE WITH SCHIZOPHRENIA: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Shim, Joo-Cheol
    Jung, D.
    Oh, M.
    Kong, B.
    Ha, T.
    Cho, D.
    Kang, J.
    Ryu, J.
    Seo, B.
    Kelly, D.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 320 - 321
12345